The NF-κB signalling pathway in osteoarthritis
• Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased...
Ausführliche Beschreibung
Autor*in: |
Rigoglou, Stella [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2013 |
---|
Schlagwörter: |
---|
Umfang: |
5 |
---|
Übergeordnetes Werk: |
Enthalten in: Urological Diseases of the Byzantine Emperors (330-1453) - 2011, Amsterdam |
---|---|
Übergeordnetes Werk: |
volume:45 ; year:2013 ; number:11 ; pages:2580-2584 ; extent:5 |
Links: |
---|
DOI / URN: |
10.1016/j.biocel.2013.08.018 |
---|
Katalog-ID: |
ELV03343400X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV03343400X | ||
003 | DE-627 | ||
005 | 20230623225826.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.biocel.2013.08.018 |2 doi | |
028 | 5 | 2 | |a GBVA2013018000026.pica |
035 | |a (DE-627)ELV03343400X | ||
035 | |a (ELSEVIER)S1357-2725(13)00286-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 540 | |
082 | 0 | 4 | |a 540 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.85 |2 bkl | ||
100 | 1 | |a Rigoglou, Stella |e verfasserin |4 aut | |
245 | 1 | 4 | |a The NF-κB signalling pathway in osteoarthritis |
264 | 1 | |c 2013 | |
300 | |a 5 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. | ||
650 | 7 | |a NF-κB |2 Elsevier | |
650 | 7 | |a Signal transduction |2 Elsevier | |
650 | 7 | |a Cartilage destruction |2 Elsevier | |
650 | 7 | |a Chondrocytes |2 Elsevier | |
650 | 7 | |a Osteoarthritis |2 Elsevier | |
700 | 1 | |a Papavassiliou, Athanasios G. |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |t Urological Diseases of the Byzantine Emperors (330-1453) |d 2011 |g Amsterdam |w (DE-627)ELV010616845 |
773 | 1 | 8 | |g volume:45 |g year:2013 |g number:11 |g pages:2580-2584 |g extent:5 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.biocel.2013.08.018 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.85 |j Kardiologie |j Angiologie |q VZ |
951 | |a AR | ||
952 | |d 45 |j 2013 |e 11 |h 2580-2584 |g 5 | ||
953 | |2 045F |a 540 |
author_variant |
s r sr |
---|---|
matchkey_str |
rigogloustellapapavassiliouathanasiosg:2013----:hnbinligahaio |
hierarchy_sort_str |
2013 |
bklnumber |
44.85 |
publishDate |
2013 |
allfields |
10.1016/j.biocel.2013.08.018 doi GBVA2013018000026.pica (DE-627)ELV03343400X (ELSEVIER)S1357-2725(13)00286-0 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 610 VZ 44.85 bkl Rigoglou, Stella verfasserin aut The NF-κB signalling pathway in osteoarthritis 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis Elsevier Papavassiliou, Athanasios G. oth Enthalten in Elsevier Urological Diseases of the Byzantine Emperors (330-1453) 2011 Amsterdam (DE-627)ELV010616845 volume:45 year:2013 number:11 pages:2580-2584 extent:5 https://doi.org/10.1016/j.biocel.2013.08.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 45 2013 11 2580-2584 5 045F 540 |
spelling |
10.1016/j.biocel.2013.08.018 doi GBVA2013018000026.pica (DE-627)ELV03343400X (ELSEVIER)S1357-2725(13)00286-0 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 610 VZ 44.85 bkl Rigoglou, Stella verfasserin aut The NF-κB signalling pathway in osteoarthritis 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis Elsevier Papavassiliou, Athanasios G. oth Enthalten in Elsevier Urological Diseases of the Byzantine Emperors (330-1453) 2011 Amsterdam (DE-627)ELV010616845 volume:45 year:2013 number:11 pages:2580-2584 extent:5 https://doi.org/10.1016/j.biocel.2013.08.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 45 2013 11 2580-2584 5 045F 540 |
allfields_unstemmed |
10.1016/j.biocel.2013.08.018 doi GBVA2013018000026.pica (DE-627)ELV03343400X (ELSEVIER)S1357-2725(13)00286-0 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 610 VZ 44.85 bkl Rigoglou, Stella verfasserin aut The NF-κB signalling pathway in osteoarthritis 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis Elsevier Papavassiliou, Athanasios G. oth Enthalten in Elsevier Urological Diseases of the Byzantine Emperors (330-1453) 2011 Amsterdam (DE-627)ELV010616845 volume:45 year:2013 number:11 pages:2580-2584 extent:5 https://doi.org/10.1016/j.biocel.2013.08.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 45 2013 11 2580-2584 5 045F 540 |
allfieldsGer |
10.1016/j.biocel.2013.08.018 doi GBVA2013018000026.pica (DE-627)ELV03343400X (ELSEVIER)S1357-2725(13)00286-0 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 610 VZ 44.85 bkl Rigoglou, Stella verfasserin aut The NF-κB signalling pathway in osteoarthritis 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis Elsevier Papavassiliou, Athanasios G. oth Enthalten in Elsevier Urological Diseases of the Byzantine Emperors (330-1453) 2011 Amsterdam (DE-627)ELV010616845 volume:45 year:2013 number:11 pages:2580-2584 extent:5 https://doi.org/10.1016/j.biocel.2013.08.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 45 2013 11 2580-2584 5 045F 540 |
allfieldsSound |
10.1016/j.biocel.2013.08.018 doi GBVA2013018000026.pica (DE-627)ELV03343400X (ELSEVIER)S1357-2725(13)00286-0 DE-627 ger DE-627 rakwb eng 540 540 DE-600 610 VZ 610 VZ 44.85 bkl Rigoglou, Stella verfasserin aut The NF-κB signalling pathway in osteoarthritis 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis Elsevier Papavassiliou, Athanasios G. oth Enthalten in Elsevier Urological Diseases of the Byzantine Emperors (330-1453) 2011 Amsterdam (DE-627)ELV010616845 volume:45 year:2013 number:11 pages:2580-2584 extent:5 https://doi.org/10.1016/j.biocel.2013.08.018 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.85 Kardiologie Angiologie VZ AR 45 2013 11 2580-2584 5 045F 540 |
language |
English |
source |
Enthalten in Urological Diseases of the Byzantine Emperors (330-1453) Amsterdam volume:45 year:2013 number:11 pages:2580-2584 extent:5 |
sourceStr |
Enthalten in Urological Diseases of the Byzantine Emperors (330-1453) Amsterdam volume:45 year:2013 number:11 pages:2580-2584 extent:5 |
format_phy_str_mv |
Article |
bklname |
Kardiologie Angiologie |
institution |
findex.gbv.de |
topic_facet |
NF-κB Signal transduction Cartilage destruction Chondrocytes Osteoarthritis |
dewey-raw |
540 |
isfreeaccess_bool |
false |
container_title |
Urological Diseases of the Byzantine Emperors (330-1453) |
authorswithroles_txt_mv |
Rigoglou, Stella @@aut@@ Papavassiliou, Athanasios G. @@oth@@ |
publishDateDaySort_date |
2013-01-01T00:00:00Z |
hierarchy_top_id |
ELV010616845 |
dewey-sort |
3540 |
id |
ELV03343400X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03343400X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623225826.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.biocel.2013.08.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013018000026.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03343400X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1357-2725(13)00286-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">540</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rigoglou, Stella</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The NF-κB signalling pathway in osteoarthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NF-κB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Signal transduction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cartilage destruction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chondrocytes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Osteoarthritis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Papavassiliou, Athanasios G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="t">Urological Diseases of the Byzantine Emperors (330-1453)</subfield><subfield code="d">2011</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV010616845</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:45</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:2580-2584</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.biocel.2013.08.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">45</subfield><subfield code="j">2013</subfield><subfield code="e">11</subfield><subfield code="h">2580-2584</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">540</subfield></datafield></record></collection>
|
author |
Rigoglou, Stella |
spellingShingle |
Rigoglou, Stella ddc 540 ddc 610 bkl 44.85 Elsevier NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis The NF-κB signalling pathway in osteoarthritis |
authorStr |
Rigoglou, Stella |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV010616845 |
format |
electronic Article |
dewey-ones |
540 - Chemistry & allied sciences 610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
540 540 DE-600 610 VZ 44.85 bkl The NF-κB signalling pathway in osteoarthritis NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis Elsevier |
topic |
ddc 540 ddc 610 bkl 44.85 Elsevier NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis |
topic_unstemmed |
ddc 540 ddc 610 bkl 44.85 Elsevier NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis |
topic_browse |
ddc 540 ddc 610 bkl 44.85 Elsevier NF-κB Elsevier Signal transduction Elsevier Cartilage destruction Elsevier Chondrocytes Elsevier Osteoarthritis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
a g p ag agp |
hierarchy_parent_title |
Urological Diseases of the Byzantine Emperors (330-1453) |
hierarchy_parent_id |
ELV010616845 |
dewey-tens |
540 - Chemistry 610 - Medicine & health |
hierarchy_top_title |
Urological Diseases of the Byzantine Emperors (330-1453) |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV010616845 |
title |
The NF-κB signalling pathway in osteoarthritis |
ctrlnum |
(DE-627)ELV03343400X (ELSEVIER)S1357-2725(13)00286-0 |
title_full |
The NF-κB signalling pathway in osteoarthritis |
author_sort |
Rigoglou, Stella |
journal |
Urological Diseases of the Byzantine Emperors (330-1453) |
journalStr |
Urological Diseases of the Byzantine Emperors (330-1453) |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
500 - Science 600 - Technology |
recordtype |
marc |
publishDateSort |
2013 |
contenttype_str_mv |
zzz |
container_start_page |
2580 |
author_browse |
Rigoglou, Stella |
container_volume |
45 |
physical |
5 |
class |
540 540 DE-600 610 VZ 44.85 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Rigoglou, Stella |
doi_str_mv |
10.1016/j.biocel.2013.08.018 |
dewey-full |
540 610 |
title_sort |
nf-κb signalling pathway in osteoarthritis |
title_auth |
The NF-κB signalling pathway in osteoarthritis |
abstract |
• Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. |
abstractGer |
• Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. |
abstract_unstemmed |
• Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
container_issue |
11 |
title_short |
The NF-κB signalling pathway in osteoarthritis |
url |
https://doi.org/10.1016/j.biocel.2013.08.018 |
remote_bool |
true |
author2 |
Papavassiliou, Athanasios G. |
author2Str |
Papavassiliou, Athanasios G. |
ppnlink |
ELV010616845 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth |
doi_str |
10.1016/j.biocel.2013.08.018 |
up_date |
2024-07-06T18:33:36.934Z |
_version_ |
1803855663658434560 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV03343400X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623225826.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.biocel.2013.08.018</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013018000026.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV03343400X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1357-2725(13)00286-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">540</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.85</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rigoglou, Stella</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The NF-κB signalling pathway in osteoarthritis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Osteoarthritis (OA) is a degenerative disease affecting all compartments of the joint. • NF-κB signalling pathway is a major catabolic pathway in OA joints. • NF-κB triggers the expression of various genes which are implicated in cartilage destruction, synovial membrane inflammation and increased subchondral bone resorption. • Targeting of the NF-κB signalling cascade is a promising therapeutic strategy for OA treatment.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NF-κB</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Signal transduction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cartilage destruction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chondrocytes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Osteoarthritis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Papavassiliou, Athanasios G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="t">Urological Diseases of the Byzantine Emperors (330-1453)</subfield><subfield code="d">2011</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV010616845</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:45</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:11</subfield><subfield code="g">pages:2580-2584</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.biocel.2013.08.018</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.85</subfield><subfield code="j">Kardiologie</subfield><subfield code="j">Angiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">45</subfield><subfield code="j">2013</subfield><subfield code="e">11</subfield><subfield code="h">2580-2584</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">540</subfield></datafield></record></collection>
|
score |
7.3984118 |